health canada semaglutide Canada's market authorisation for our generic Injection makes us the first company to receive this authorisation in Canada. This milestone reflects our deep focus on complex generics and peptide based A cheaper version of Ozempic

Evidence-based levers that reliably move the needle: A sustainable calorie deficit with adequate protein Resistance training plus daily movement Sleep and stress management (often underestimated) Clinician-guided options when appropriate, including FDA-approved obesity medications (e.g., Wegovy and Zepbound ) and weight loss injections A good rule of thumb: don't outsource a fundamentals problem to an unproven tool

For the full list of side effects, look at the package insert that comes with your medication (find those here for Zepbound, Mounjaro, Wegovy, and Ozempic)

Together, these findings highlight that both pharmacological antidepressants and bioactive dietary compounds like flavonoids can shift KP metabolism toward neuroprotective pathways, offering potential avenues to alleviate inflammation-driven depressive pathology

Insurance formulary coverage, manufacturer savings programs, and generic biosimilar pathways entering the market in 2026 further reduce cost and access barriers for most patients

As depicted in Table 4, exenatide exhibited the broadest spectrum, with a total of 8 potential signals indicating GLP-1 RA-induced AP, ranging from pancreatic abscess (ROR 4.20, 95% CI 1.0317.03) to pancreatic phlegmon (ROR 84.53, 95% CI 21.86326.90)